Clinical Trial Update: The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing the effect of renal impairment on the pharmacokinetics of oral treprostinil in pulmonary arterial hypertension; complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Orenitram (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension, Renal Dysfunction | Phase 1 | Status: COMPLETED